Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction
- 10 October 2007
- journal article
- Published by Elsevier BV in Virology
- Vol. 367 (1), 10-18
- https://doi.org/10.1016/j.virol.2007.05.009
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM066313, GM071023, GM073901, HL077322)
This publication has 47 references indexed in Scilit:
- Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the NucleusJournal of Virology, 2006
- Shiga Toxin Facilitates Its Retrograde Transport by Modifying Microtubule DynamicsMolecular Biology of the Cell, 2006
- Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectorsVirology, 2006
- Adeno-Associated Virus Type 2 Contains an Integrin α5β1 Binding Domain Essential for Viral Cell EntryJournal of Virology, 2006
- Eclipse Phase of Herpes Simplex Virus Type 1 Infection: Efficient Dynein-Mediated Capsid Transport without the Small Capsid Protein VP26Journal of Virology, 2006
- A Common Mechanism for Cytoplasmic Dynein-Dependent Microtubule Binding Shared among Adeno-Associated Virus and Adenovirus SerotypesJournal of Virology, 2006
- rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashionMolecular Therapy, 2006
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteinNature Biotechnology, 2004
- Cell-Type-Specific Characteristics Modulate the Transduction Efficiency of Adeno-Associated Virus Type 2 and Restrain Infection of Endothelial CellsJournal of Virology, 2002
- Vinblastine paracrystals from cultured cells are calcium-stableExperimental Cell Research, 1984